Combination therapy with oral minoxidil and dutasteride in the treatment of male patterned baldness: A case report
Open Access
- 10 January 2022
- journal article
- research article
- Published by Scientific Scholar
- Vol. 2, 4
Abstract
Androgenetic alopecia is a medical condition with a deep social and psychological impact on the affected individuals and is characterized by progressive hair thinning, leading to hair loss over the scalp in both males and females. Minoxidil in oral form is primarily an antihypertensive drug, whose mechanism of action is not completely known. Dutasteride is a 5-alpha reductase inhibitor, acting on both alpha-1 and alpha-2 receptors. The author combined these two agents for the treatment of male patterned baldness and found that this combination imparts a visible increase in hair thickness, density, and new hair growth in the patient, within a short period causing minimal side effects.Keywords
This publication has 8 references indexed in Scilit:
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic AssessmentDermatology and Therapy, 2020
- Oral Minoxidil: A Possible New Therapy for Androgenetic AlopeciaJournal of Cutaneous Medicine and Surgery, 2020
- Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapyDermatologic Therapy, 2018
- Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patientsDermatologic Therapy, 2018
- Dutasteride: A Review of its Use in the Management of Prostate DisordersClinical Medicine Insights: Therapeutics, 2011
- ANDROGENETIC ALOPECIADermatologic Clinics, 2000
- Evaluation of oral minoxidil in the treatment of alopecia areataArchives of Dermatology, 1987